Dr. Vleugels is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
221 Longwood Ave
Boston, MA 02115Phone+1 617-732-4918
Education & Training
- Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2005 - 2008
- Brigham and Women's HospitalInternship, Internal Medicine, 2004 - 2005
- Vanderbilt University School of MedicineClass of 2004
Certifications & Licensure
- FL State Medical License 2022 - 2026
- ME State Medical License 2021 - 2026
- RI State Medical License 2021 - 2026
- CT State Medical License 2021 - 2025
- MA State Medical License 2008 - 2025
- NH State Medical License 2021 - 2025
- VT State Medical License 2022 - 2024
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 1 citationsMepolizumab for refractory eosinophilic fasciitis: a retrospective analysis from two tertiary care centres.Stephanie N Sanchez-Melendez, Katharina S Shaw, Catherina X Pan, Dustin L Taylor, Neda Shahriari
Clinical and Experimental Rheumatology. 2023-08-01 - 5 citationsInterferon subverts an AHR-JUN axis to promote CXCL13T cells in lupus.Calvin Law, Vanessa Sue Wacleche, Ye Cao, Arundhati Pillai, John Sowerby
Nature. 2024-07-01 - 90 citationsTofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative TreatmentDrew J.B. Kurtzman, Natalie A. Wright, Janice Lin, Alisa N. Femia, Joseph F. Merola
JAMA Dermatology. 2016-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: